Nov. 28, 2022
Biotechnology and pharmaceutical companies are increasingly investing in the development of therapeutics to treat hearing disorders. In just the past few months, the industry has witnessed the FDA approval of Pedmark, a new drug to treat ototoxicity associated with pediatric patients 1 month or older, as well as the acquisition of Akouos by Eli Lilly for nearly $500M dollars. In